Episode 192: Michael Gilman on the future of RNA drugs, plus #JPM22 in review and more Biogen news
First, STAT health tech correspondent Katie Palmer joins us to recap the J.P. Morgan Healthcare Conference. Then, we discuss the latest twist in Biogen's quest to expand the use of Aduhelm and what it...
13 Jan 202234min
Episode 191: Craig Spencer on the Omicron surge + biotech in 2022, & the Elizabeth Holmes verdict
First, emergency room physician Craig Spencer joins us to talk about how the Omicron variant is impacting New York City and what the coming months have in store. Then, we look ahead to the New Year in...
6 Jan 202231min
Episode 190: Covid in 2022, J.P. Morgan bows to pressure, & the year in review
We've come to our last episode of the year, and first, STAT’s Helen Branswell joins us to talk about Omicron, boosters, and the past and future of the Covid-19 pandemic. Then, we'll review the year th...
16 Des 202135min
Episode 189: Biogen, Biogen, Biogen, with a dash of Omicron
On this week's episode, we kick off the conversation with an update on what researchers are discovering about the Omicron variant of the coronavirus, including new findings from a study involving the ...
9 Des 202129min
Episode 188: Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron
Will the first Covid-19 pill be all that useful? How worrisome is Omicron? And when will it be safe to congregate? First, STAT's Matthew Herper joins us to talk about a tense debate among FDA advise...
2 Des 202132min
Episode 187: Biogen’s scientific succession & Michael Osterholm on pandemic Thanksgiving
First, epidemiologist Michael Osterholm of the University of Minnesota joins us to talk about Covid-19 case counts, vaccination rates, and the state of the pandemic as we head into the holidays. Then,...
18 Nov 202135min
Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicine
Rebecca Robbins of the New York Times joins us to discuss the escalating tension between Moderna and the National Institutes of Health over just who invented a Covid-19 vaccine. Then, STAT's Olivia Go...
11 Nov 202130min
Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform saga
STAT's Rachel Cohrs drops in to talk about the latest updates in drug pricing reform. Then, John Maraganore joins us to talk about his decision to step down as CEO of Alnylam Pharmaceuticals after alm...
4 Nov 202128min
